Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations

被引:4
作者
Yandrapalli, Srikanth [1 ]
Malik, Aaqib H. [2 ,3 ]
Namrata, Fnu [2 ,3 ]
Pemmasani, Gayatri [4 ]
Bandyopadhyay, Dhrubajyoti [2 ,3 ]
Vallabhajosyula, Saraschandra [5 ]
Aronow, Wilbert S. [2 ,3 ]
Frishman, William H. [3 ,6 ]
Jain, Diwakar [2 ,3 ]
Cooper, Howard A. [2 ,3 ]
Panza, Julio A. [2 ,3 ]
机构
[1] Harvard Med Sch, Div Cardiol, Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Westchester Med Ctr, Dept Cardiol, Valhalla, NY USA
[3] New York Med Coll, Valhalla, NY 10595 USA
[4] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA
[5] Wake Forest Univ, Bowman Gray Sch Med, Sect Cardiol, Winston Salem, NC USA
[6] Westchester Med Ctr, Dept Med, Valhalla, NY USA
关键词
Acute myocardial infarction; Diabetes mellitus; Heart failure; Risk factors; Outcomes; NONINSULIN ANTIHYPERGLYCEMIC DRUGS; MYOCARDIAL-INFARCTION; OUTCOMES; IMPACT; MORTALITY; BENEFITS; INSULIN; SAFETY;
D O I
10.1016/j.ijcard.2021.11.086
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: There is a paucity of information regarding how cardiovascular risk factors (RF) modulate the impact of diabetes mellitus (DM) on the heart failure hospitalization (HFH) risk following an acute myocardial infarction (AMI). Methods: Adult survivors of an AMI were retrospectively identified from the 2014 US Nationwide Readmissions Database. The impact of DM on the risk for a 6-month HFH was studied in subgroups of RFs using multivariable logistic regression to adjust for baseline risk differences. Individual interactions of DM with RFs were tested. Results: Of 237,549 AMI survivors, 37.2% patients had DM. Primary outcome occurred in 12,934 patients (5.4%), at a 106% higher rate in DM patients (7.9% vs 4.0%, p < 0.001), which was attenuated to a 45% higher adjusted risk. Higher HFH risk in DM patients was consistent across subgroups and significant interactions were present between DM and other RFs. The increased HFH risk with DM was more pronounced in patients without certain HF RFs compared with those with these RFs [age < 65: OR for DM 1.84 (1.58-2.13) vs age >= 65: OR 1.34 (1.24-1.45); HF absent during index AMI: OR for DM 1.87 (1.66-2.10) vs HF present: OR 1.24 (1.14-1.34); atrial fibrillation absent: OR for DM 1.57 (1.46-1.68) vs present: OR 1.19 (1.06-1.33); Pinteraction < 0.001 for all]. Similar results were noted for hypertension and chronic kidney disease. Conclusions: AMI survivors with DM had a higher risk of 6-month HFHs. The impact of DM on the increased HFH risk was more pronounced in patients without certain RFs suggesting that more aggressive preventive strategies related to DM and HF are needed in these subgroups to prevent or delay the onset of HFHs.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 50 条
[21]   Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment [J].
Sun, Sijia ;
Jiang, Yu ;
Zhen, Zhe ;
Lai, Wing-Hon ;
Liao, Songyan ;
Tse, Hung-Fat .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (159) :1-8
[22]   Increasing Post-Myocardial Infarction Heart Failure Incidence in Elderly Patients A Call for Action [J].
Liang, Chang-seng ;
Delehanty, Joseph D. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (01) :21-23
[23]   Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial [J].
Sarma, Satyam ;
Mentz, Robert J. ;
Kwasny, Mary J. ;
Fought, Angela J. ;
Huffman, Mark ;
Subacius, Haris ;
Nodari, Savina ;
Konstam, Marvin ;
Swedberg, Karl ;
Maggioni, Aldo P. ;
Zannad, Faiez ;
Bonow, Robert O. ;
Gheorghiade, Mihai .
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (02) :194-202
[24]   Therapies to prevent heart failure post-myocardial infarction. [J].
Thomas K.L. ;
Velazquez E.J. .
Current Heart Failure Reports, 2005, 2 (4) :174-182
[25]   A New Model of Heart Failure Post-Myocardial Infarction in the Rat [J].
Li, Honglei ;
Huang, Jiansheng ;
Liu, Caihong ;
Zhang, Zhentao ;
Song, Kuiquan ;
Ma, Ke ;
Dennewitz, Connor W. ;
Wang, Shijun .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (172)
[26]   Use of valsartan in post-myocardial infarction and heart failure patients [J].
Liu, Peter P. ;
Maggioni, Aldo ;
Velazquez, Eric J. .
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2006, 7 :S19-S22
[27]   Natriuretic Peptide Guidance for Post-Myocardial Infarction Care: An Opportunity to Prevent Heart Failure Progression [J].
Tang, W. H. Wilson ;
Zheng, Weili .
CIRCULATION-HEART FAILURE, 2023, 16 (05) :400-402
[28]   Established and Emerging Pharmacological Therapies for Post-Myocardial Infarction Patients with Heart Failure: a Review of the Evidence [J].
De Luca, Leonardo .
CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (05) :723-735
[29]   Dapagliflozin in Post-Myocardial Infarction Acute Decompensated Heart Failure: Daffodil Study [J].
Jariwala, Pankaj ;
Kulkarni, Gururaj Pramod ;
Punjani, Arshad ;
Boorugu, Hari Kishan ;
Madhawar, Dilip Babu ;
Gude, Dilip .
JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2024, 10 (02) :71-76
[30]   Where Are We With Treatment and Prevention of Heart Failure in Patients Post-Myocardial Infarction? [J].
Carberry, Jaclyn ;
Marquis-Gravel, Guillaume ;
O'Meara, Eileen ;
Docherty, Kieran F. .
JACC-HEART FAILURE, 2024, 12 (07) :1157-1165